These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12168607)

  • 21. Proceedings of the International Conference for the Bone and Joint Decade 2000-2010. Tokyo, Japan. April 17-19, 2002.
    J Rheumatol Suppl; 2003 Aug; 67():1-68. PubMed ID: 14746337
    [No Abstract]   [Full Text] [Related]  

  • 22. Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action.
    Katz SJ; Russell AS
    Curr Opin Rheumatol; 2011 May; 23(3):278-81. PubMed ID: 21448012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infection prophylaxis in antirheumatic therapy: emphasis on vaccination.
    Kavanaugh A
    Curr Opin Rheumatol; 2009 Jul; 21(4):419-24. PubMed ID: 19444117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic rheumatic diseases in childhood and GH-treatment: new insights. Milan, Italy, May 14, 1999.
    Bardare M
    Clin Exp Rheumatol; 2000; 18(6):781-3. PubMed ID: 11138349
    [No Abstract]   [Full Text] [Related]  

  • 25. International course on "Immunological Techniques in Paediatric Rheumatology". International Symposium on "Juvenile Arthritis". Proceedings. Pavia, Italy, 5-11 October 1986.
    Scand J Rheumatol Suppl; 1987; 66():1-136. PubMed ID: 3330293
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical immunology of rheumatic processes].
    Genth E
    Med Welt; 1978 Oct; 29(41):1609-15. PubMed ID: 151180
    [No Abstract]   [Full Text] [Related]  

  • 27. [Inflammatory aspects and therapeutic possibilities of rheumatic diseases. Introduction].
    Ballabio CB; Fantini F
    Minerva Med; 1973 Jun; 64(46):2385-94. PubMed ID: 4124964
    [No Abstract]   [Full Text] [Related]  

  • 28. Advances in targeted therapies VIII. Proceedings of the Eighth International Symposium on Advances in Targeted Therapy. April 5-9, 2006. Sorrento, Italy.
    Breedveld FC; Kalden JR; Smolen JS
    Ann Rheum Dis; 2006 Nov; 65 Suppl 3(Suppl 3):iii1-89. PubMed ID: 17038463
    [No Abstract]   [Full Text] [Related]  

  • 29. [Nutrition in rheumatic diseases].
    Denisov LN
    Revmatologiia (Mosk); 1987; (2):38-44. PubMed ID: 3313637
    [No Abstract]   [Full Text] [Related]  

  • 30. Advances in Targeted Therapies VI. Proceedings of the 6th International Symposium. Venice, Italy, 28 April-2 May 2004.
    Ann Rheum Dis; 2004 Nov; 63 Suppl 2():ii1-101. PubMed ID: 15479863
    [No Abstract]   [Full Text] [Related]  

  • 31. First international conference on rheumatic diseases in pregnancy.
    Buyon JP; Yaron M; Lockshin MD
    Arthritis Rheum; 1993 Jan; 36(1):59-64. PubMed ID: 8424837
    [No Abstract]   [Full Text] [Related]  

  • 32. [The role of sex hormones in rheumatic diseases].
    Siniachenko TIu; Shtoba LA; Kosheleva EN
    Klin Med (Mosk); 1991 Nov; 69(11):29-32. PubMed ID: 1808400
    [No Abstract]   [Full Text] [Related]  

  • 33. Vitamin D endocrine system and the immune response in rheumatic diseases.
    Cutolo M; Plebani M; Shoenfeld Y; Adorini L; Tincani A
    Vitam Horm; 2011; 86():327-51. PubMed ID: 21419278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complexities in defining remission in rheumatic diseases.
    Pincus T; Kavanaugh A; Aletaha D; Smolen J
    Clin Exp Rheumatol; 2006; 24(6 Suppl 43):S-1-6. PubMed ID: 17083755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accelerated atherosclerosis in autoimmune rheumatic diseases.
    Shoenfeld Y; Gerli R; Doria A; Matsuura E; Cerinic MM; Ronda N; Jara LJ; Abu-Shakra M; Meroni PL; Sherer Y
    Circulation; 2005 Nov; 112(21):3337-47. PubMed ID: 16301360
    [No Abstract]   [Full Text] [Related]  

  • 36. [Systemic therapy with glucocorticoids. Treatment of rheumatic diseases].
    Möller B
    Pharm Unserer Zeit; 2003; 32(4):302-5. PubMed ID: 12899067
    [No Abstract]   [Full Text] [Related]  

  • 37. Endothelial dysfunction in rheumatic autoimmune diseases.
    Murdaca G; Colombo BM; Cagnati P; Gulli R; Spanò F; Puppo F
    Atherosclerosis; 2012 Oct; 224(2):309-17. PubMed ID: 22673743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rheumatic manifestations of endocrine diseases.
    Markenson JA
    Curr Opin Rheumatol; 2010 Jan; 22(1):64-71. PubMed ID: 19935068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fixed drug eruption due to meloxicam.
    Ozdemir SK; Erkekol FO; Aydin O; Celik GE; Misirligil Z
    J Investig Allergol Clin Immunol; 2011; 21(5):419-20. PubMed ID: 21905514
    [No Abstract]   [Full Text] [Related]  

  • 40. New cytokine targets in inflammatory rheumatic diseases.
    Connell L; McInnes IB
    Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):865-78. PubMed ID: 16980211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.